Nanoparticles and targeted drug delivery in cancer therapyBehdokht Bahrami, Farhad Jadidi‐Niaragh, Mohammad Hojjat‐Farsangi et al.|Immunology Letters|2017Cited by 507
Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancerMohammad Hossein Kazemi, Farhad Jadidi‐Niaragh, Sahar Raoofi Mohseni et al.|Journal of Cellular Physiology|2017Cited by 150
Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing miceGhasem Ghalamfarsa, Farhad Jadidi‐Niaragh, Mohammad Hojjat‐Farsangi et al.|Journal of Cellular Physiology|2018Cited by 75
The role of DEAD‐box RNA helicase p68 (DDX5) in the development and treatment of breast cancerVida Hashemi, Farhad Jadidi‐Niaragh, Ali Masjedi et al.|Journal of Cellular Physiology|2018Cited by 61
Application of nanomedicine for crossing the blood–brain barrier: Theranostic opportunities in multiple sclerosisGhasem Ghalamfarsa, Farhad Jadidi‐Niaragh, Mohammad Hojjat‐Farsangi et al.|Journal of Immunotoxicology|2016Cited by 52